Author

Efi Athieniti

Cyprus Institute of Neurology and GeneticsORCID 0000-0002-0091-5986Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:multiome· 1

Frequent Co-Authors

George M. SpyrouiD· 2 shared George MinadakisiD· 2 shared Grigoris GeorgiouiD· 1 shared Kyriaki SavvaiD· 1 shared Marilena M. BourdakouiD· 1 shared Nestoras KarathanasisiD· 1 shared Sotiroula AfxentiiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

George M. SpyrouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-omics dissection of Parkinson's patient subgroups associated with motor and cognitive severity

Efi Athieniti, Sotiroula Afxenti, George Minadakis, George M. Spyrou

The paper uses multi-omics data to identify molecular factors associated with motor and cognitive severity in Parkinson's disease and stratifies patients into subgroups with distinct severity profiles.

Neurobiology of Disease · Feb 2, 2026Peer-reviewedBioinformatics

Stage-specific gene ratios highlight genes and mechanisms related to presymptomatic and symptomatic Multiple Myeloma

Grigoris Georgiou, George Minadakis, Nestoras Karathanasis, Kyriaki Savva, Efi Athieniti, Marilena M. Bourdakou, George M. Spyrou

The paper identifies stage-specific genes and pathways in Multiple Myeloma using monotonic expressed genes (MEGs) and gene pair ratios, showing their potential as biomarkers for disease progression.

bioRxiv · Nov 4, 2024 · PreprintBioinformatics